Dasatinib-Induced Colitis with Rectal Sparing in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront Therapy: Case Report

Dasatinib is a BCR-ABL tyrosine kinase inhibitor which was approved in 2006 for the treatment of adults diagnosed with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase (CP) and accelerated (myeloid or lymphoid blast) phase and CML with resistance or intolerance...

Full description

Bibliographic Details
Main Authors: Zakaria Maat, Kamran Mushtaq, Mohamed A. Yassin
Format: Article
Language:English
Published: Karger Publishers 2021-10-01
Series:Case Reports in Oncology
Subjects:
Online Access:https://www.karger.com/Article/FullText/516794